Anthony Repay is currently serving as Laboratory Director of Method Testing Laboratories in Tampa, FL. Anthony started his career as the head food and environmental microbiologist at a Chicago-based testing laboratory before joining the cannabis science community. Since joining cannabis, Anthony has tried to innovate and push the cannabis microbiology community by publishing peer-reviewed papers, speaking on proper quality control and volunteering in several national wide cannabis groups. 

During our conversation we discuss:

• How growers can incorporate microbial testing into their processes 
  
• Sources of microbial contamination and tips for prevention 
  
• How differences in microbial regulations influence growers in certain states 
  
• Remediation technologies 
  
• and more 
  

Thanks to This Episode’s Sponsor: RS BioTherapeutics 

RS BioTherapeutics’ first investigational compound (RSBT-001) is a nebulized, semi-synthetic, cannabidiolic acid complex in development to address exacerbation and prevent progression of both acute and chronic pulmonary inflammation related to respiratory diseases including COPD, SARS-COV-2, Cystic Fibrosis, Asthma, Bronchitis, and Acute Respiratory Distress Syndrome. More information on RS BioTherapeutics can be found at www.rsbiotherapeutics.com.

Additional Resources

• Anthony Repay on LinkedIn
  
• Method Testing Laboratories website
  
• Cannabis Microbial Testing Regulations by State [Interactive Tool]
  
• Request an Invitation to CannMed 23
  
• Review the Podcast!
  
• CannMed Archive
  
• CannMed Community Board [Facebook Group]
  
• Healthcare Provider Medical Cannabis Research Study